Evidence map›Paper›PMID 32646888›Full record

ArticleHaematologica2021

A homozygous missense variant in UBE2T is associated with a mild Fanconi anemia phenotype.

Laura Schultz-Rogers, Francis P Lach, Kimberly A Rickman, Alejandro Ferrer, Abhishek A Mangaonkar, Tanya L Schwab, Christopher T Schmitz, Karl J Clark, Nikita R Dsouza, Michael T Zimmermann and 5 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Laura Schultz-RogersMayo Clinic.
Francis P LachThe Rockefeller University.
Kimberly A RickmanThe Rockefeller University.
Alejandro FerrerMayo Clinic.
Abhishek A MangaonkarMayo Clinic.
Tanya L SchwabMayo Clinic.
Christopher T SchmitzMayo Clinic.
Karl J ClarkMayo Clinic.
Nikita R DsouzaMedical College of Wisconsin.
Michael T ZimmermannMedical College of Wisconsin.
Mark LitzowMayo Clinic.
Nicole JacobiHennepin County Medical Center.
Eric W KleeMayo Clinic.
Agata SmogorzewskaThe Rockefeller University.
Mrinal M PatnaikMayo Clinic.
WinnMed · USRockefeller University · USMedical College of Wisconsin · USHennepin County Medical Center · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
The role of nucleases in interstrand crosslink repairR01HL120922 · NHLBI · ROCKEFELLER UNIVERSITY · PI SMOGORZEWSKA, AGATA · 2014 to 2018
$2.1M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001866NHLBI NIH HHS R01 HL120922NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fanconi AnemiaFanconi Anemia Complementation Group ProteinsHumansPhenotypeUbiquitin-Conjugating EnzymesFanconi Anemia Complementation Group ProteinsUBE2T protein, humanUbiquitin-Conjugating Enzymes

Identifiers

PMID32646888
PMCPMC8018101
OpenAlexW3041819240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.